title: Dose-related antinociceptive effects of intravenous buprenorphine in cats.
abstract: The dose-related antinociceptive effects of intravenous (IV) buprenorphine were evaluated in cats. Thermal (TT) and mechanical threshold (MT) devices were used for nociceptive stimulation. After baseline threshold recordings, buprenorphine was administered IV (0.01, 0.02 or 0.04 mg/kg; B1, B2 and B4, respectively) in a randomised, blinded and cross-over study. Data were analysed by ANOVA (P<0.05) using 95% confidence intervals (CI). TT increased 15, 30, 45 min and 1 (5.2+/-2.7 degrees C), 2, 3 and 4 h after B1; 15, 30, 45 min and 1 (5.1+/-3.9 degrees C) and 2 h after B2, and 15, 30, 45 min and 1 (5.4+/-3.3 degrees C), 2, 3, 6 and 8 h after B4. MT increased 15 and 45 min after B2 (260+/-171 mmHg), and 30 (209+/-116 mmHg) and 45 min and 1 and 2 h after B4. At 45 min, MT values were significantly higher after B2 compared to B1 (P<0.05). With MT, B2 and B4 produced more antinociception and longer duration of action than B1, respectively. No dose response to thermal stimulation was detected.
authors.affiliation: Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, 2015 Linden Drive, Madison, WI 53706-1100, USA. psteagall@svm.vetmed.wisc.edu
authors.forename: Paulo V M
authors.initials: PV
authors.lastname: Steagall
authors.forename: Fernanda B
authors.initials: FB
authors.lastname: Mantovani
authors.forename: Polly M
authors.initials: PM
authors.lastname: Taylor
authors.forename: Mike J
authors.initials: MJ
authors.lastname: Dixon
authors.forename: Stelio P L
authors.initials: SP
authors.lastname: Luna
mesh_terms: D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D002047:Buprenorphine / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D002415:Cats / Q000378:metabolism*; D018592:Cross-Over Studies; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D006358:Hot Temperature / Q000009:adverse effects; D007262:Infusions, Intravenous / Q000662:veterinary; D008297:Male; D010146:Pain / Q000188:drug therapy / Q000662:veterinary*; D011312:Pressure / Q000009:adverse effects; D011897:Random Allocation
chemical_list: D000701:Analgesics, Opioid; D002047:Buprenorphine